Approval · Notice of Compliance 795 · 2002
APO-WARFARIN: Notice of Compliance 795
Issued April 16, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 795
- Date
- April 16, 2002
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Anticoagulant
- Canadian reference product
- COUMADIN (Dupont Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-WARFARIN | 02245618 | Marketed |
Medicinal ingredients
- WARFARIN SODIUM 3 MG per TAB